International Patent Roundtable Featuring Comparative Discussion of Product-by-Process Claim Strategy in the U.S. and Japan
26 June 2017
In the case of emerging technologies such as stem cells and nanotechnology, inventions are frequently claimed in product-by-process format when the exact physical differences of the end products are not yet known. Recent Supreme Court precedent in Japan has created turmoil for patent applicants seeking to pursue product-by-process claims, though they remain a well-accepted claiming format in the U.S.
Join us for an interactive roundtable discussion of comparative claim drafting strategies for protecting these types of inventions in the U.S. and Japan, as well as opportunities for enforcing, challenging, and defending these types of claims.
People
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.